Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – THE WEEK
What is very clear is that two doses are required to maximise protection
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
Business13 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News8 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
Business6 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Noosa News20 hours agoGold Coast father speaks out after he and his son were shot and stabbed in Surfers